The "Meet Our Researchers" series showcases the incredible scholars at Stanford’s Center on Democracy, Development and the Rule of Law (CDDRL). Through engaging interviews conducted by our undergraduate research assistants, we explore the journeys, passions, and insights of CDDRL’s faculty and researchers.

What role do middle or “auxiliary” powers — like India, Brazil, or Turkey — play in this evolving landscape of great power competition?

This is one of the biggest differences between today and the Cold War. Back then, the system was much more binary. Today, the world is more fragmented. I think of it as a race: the U.S. is ahead, China is closing the gap, and everyone else is running behind. But they’re running. They have agency. They’re not just sitting on the sidelines.

Countries like India, South Africa, Turkey, and Brazil are swing states. They’re not going to line up neatly with Washington or Beijing. BRICS is a perfect example — democracies and autocracies working in the same grouping. The U.S. has to get used to living with that uncertainty. We need to engage, not withdraw.

And at the same time, while the U.S. seems to be retreating from some of its instruments of influence, China appears to be expanding. What worries you about this divergence?

It’s striking. We’re cutting back on USAID, pulling out of multilateral institutions, shutting down things like Voice of America, Radio Free Asia, Radio Free Europe, and cutting back on diplomats. Meanwhile, the Chinese are expanding their presence, their multilateral influence, their media footprint, and their diplomacy.

If the autocrats are organized, the democrats have to be organized too. We can’t just step back and assume things will turn out fine. That’s not how competition works.
 

During the Cold War, despite intense rivalry, the U.S. and USSR cooperated on nuclear nonproliferation and arms control. How do you see cooperation taking shape in today’s U.S.–China rivalry?

That’s a really important point. Cooperation in the Cold War wasn’t just about deterring the Soviets — it was also about working with them when we had overlapping interests. The Nuclear Nonproliferation Treaty of 1968 was a monumental achievement. It was signed at the height of the Vietnam War, while we were literally fighting proxy conflicts, and yet we found common ground on nuclear weapons.

I think something similar can and should happen now. Even if we’re competing with China, and even with Russia, there are areas where cooperation is in everyone’s interest: nuclear arms control, nonproliferation of dangerous technologies like AI and bioweapons, and climate change. These are existential issues. We cooperated with our adversaries in the past; we should be able to do it again.

One of the big debates in international relations is about the role of ideology. How much does ideology matter in this current geopolitical context?

It matters a lot. My book isn’t called Great Powers — it’s called Autocrats vs. Democrats for a reason. I believe ideas and regime type shape international politics.

Putinism and Xi Jinping Thought are exported differently. Putinism — illiberal nationalism — has ideological allies in Europe and here in the U.S. Xi’s model is more economically attractive to parts of the Global South. Power matters, of course, but it’s not the only thing.

You can see this clearly if you compare Obama and Trump. There was no big structural power shift between 2016 and 2017, but their worldviews were radically different. That’s evidence that ideas and individuals matter a great deal in shaping foreign policy.
 

You’ve warned about the dangers of U.S. retrenchment. Are there historical moments that you see as parallels to today?

I worry about a repeat of the 1930s. When Italy invaded Ethiopia, Americans said, “Where’s Ethiopia?” When Japan invaded China, they said, “Why do we care?” Then came 1939. Stalin and Hitler invaded Poland, and we still said, “That’s not our problem.” Eventually, it became our problem.

If we disengage now, we may find ourselves facing similar consequences. That’s part of why I wrote this book — to push back against the idea that retrenchment is safe. It’s not.

To close, what advice would you give to students who want to build careers like yours? And, could you recommend a book or two for young people entering this field?

Be more intentional than I was. Focus on what you want to do, not just what you want to be. Develop your ideas first, then go into government or academia to act on them. Don’t go into public service just for a title. I saw too many people in government who were there just to “be” something, without a clear agenda. The “to do” should come first; the “to be” comes later.

As for books, my own book, Autocrats vs. Democrats: China, Russia, America, and the New Global Disorder, is coming out soon — you can pre-order it. But the two books that shaped me the most when I was young are Crane Brinton’s The Anatomy of Revolution and Guillermo O’Donnell and Philippe Schmitter’s Transitions from Authoritarian Rule.

As the world becomes increasingly interconnected through digital infrastructure, the governance of critical technologies has emerged as a central issue in global politics. Once dominated by Western powers, the standard setting of emerging technologies such as 5G, artificial intelligence, and the Internet of Things  is tilting toward East Asia, particularly China and South Korea. Their expanding role in defining global technology rules raises questions: How do emerging powers influence international norms through transnational platforms? What role do multinational firms play in the competition to set technical standards? And how does the shift in international digital governance affect the global distribution of technological power?

These are among the core questions guiding the research of Yingqiu Kuang, a 2024–25 Shorenstein Postdoctoral Fellow on Contemporary Asia at the Walter H. Shorenstein Asia-Pacific Research Center (APARC). The fellowship is now accepting applications for the 2026-27 cycle. 

Drawing on a mixed-method approach that combines a novel dataset of 5G standard proposals from more than 400 multinational enterprises with over 100 interviews conducted across China and elsewhere, Kuang’s research reveals how these firms strategically navigate and transform complex global rulemaking environments. By integrating perspectives from comparative political economy, international business, and non-market strategy, her work offers new insights into how emerging economies are reshaping the global technological order.

We spoke with Dr. Kuang about her ongoing research, her experience at APARC, and her reflections on the future of global digital governance. The conversation has been lightly edited for length and clarity.

Sign up for APARC newsletters to receive our experts' updates >

Tell us a bit about your research project

I am currently working on my first book manuscript, entitled A Mosaic of Mundane Innovations: Emerging Powers, Multinational Firms, and Global 5G Technology Rules. It investigates a pivotal transformation currently underway in the global order: China and other East Asian states are reshaping the governance of critical technologies, especially in 5G telecommunications. Through transnational standard-setting and rulemaking, they are playing a leading role in the new era of digital transformation.

The project asks two key questions: First, why are nearly half of the global 5G standards coming from multinational enterprises (MNEs) of emerging markets such as China and South Korea? Second, how are their engagements in the global technology competition different from those of traditional technological superpowers during earlier waves of disruptive innovation?

My research reveals the novel strategic repertoire of these emerging economy MNEs. By strategically orchestrating domestic and supranational institutions in technology rulemaking, they have transformed institutional complexity into a global competitive advantage and driven the ascent of China and other East Asian economies in the new global technology complex.  

The project offers two important implications. First, at a time when the world’s attention is focused on state-level geopolitical competition, my research highlights the crucial and often underestimated role of transnational private governance in shaping the outcomes of the global tech race. Second, by revealing a new and more complex pattern of state–business interplay, my research underscores the renewed importance of studying economic dynamism and governance in Asia and beyond in the digital age.

What initially drew you to study your current research topic?

My journey to this topic began not with a theory, but with a simple curiosity about what lies beneath the big numbers. When I was working as a policy researcher at the Asia Pacific Foundation of Canada, I was involved in a multi-year project tracing two-way foreign direct investment (FDI) flows between Canada and Asia. But as I began to look more closely at the aggregated data and analyze their patterns, I found myself constantly wondering: What does each FDI project actually look like on the ground? How do multinational firms interact with local communities and governments? And most importantly, how does innovation really happen in these economies?

These questions drew me toward the firm-level dynamics that large datasets often obscure. As I dug deeper, I realized that in critical technology sectors, emerging economies such as China and South Korea were not just catching up but were beginning to lead, often leapfrogging established Western giants. And surprisingly, this ascent was being driven by the firms themselves, not merely by top-down government directives. This puzzle became the foundation of my book project.

What are some of the largest challenges you have identified in studying rule-making on transnational platforms and global technology governance more broadly?

There are two main challenges that I am still working to address in my research. The first is a fundamental disconnect between the actual practice of global technology governance and the public narrative surrounding it. On one hand, technology rulemaking has long been perceived as a mundane, apolitical process. It typically involves engineers debating minute technical parameters to find optimal solutions to concrete problems. On the other hand, the evolving U.S.-China rivalry has amplified the geopolitical implications of these very rules, capturing the attention of political leaders and the public.

This disconnect creates a fascinating challenge, which I encountered firsthand in my fieldwork: engineers focused on technical minutiae, while executives and policymakers debated grand strategy. Bridging this gap — understanding how technology should best be developed and governed — is a central intellectual task of my work.

The second major challenge is data availability. Because this work was historically seen as purely technical, many international organizations involved in global technology governance have maintained poor archival practices. A crucial next step for the entire field — and a personal passion of mine — is to develop new methods for archiving and analyzing the day-to-day activities of global rulemaking. This would not only expand the scope of my own research but also provide a foundational public good for other scholars seeking to understand this critical intersection of technology, business, society, and global politics.

How has your time at APARC aided your research?

At APARC, I have benefited from what at first seems like a paradox: a lively intellectual community and the rare luxury of a quiet working space. On one hand, the seminars, workshops, and events hosted at APARC and other campus organizations gave me countless opportunities to engage with scholars across disciplines. Their intellectual energy greatly broadened my perspective on Asia and the world. On the other hand, I was also fortunate to enjoy the quiet, friendly, and focused environment of the APARC office, which allowed me to both recharge and concentrate deeply on my research. 

Did you discover anything surprising while you were here?

What surprised me most was the balance between structure and spontaneity at APARC. On one hand, I learned a great deal from the Center’s formal events — seminars, fireside chats, and interdisciplinary workshops that brought together scholars of Asia from across Stanford and beyond. On the other hand, some of the most inspiring moments came in less expected settings: impromptu hallway conversations in Encina Hall, coffee chats in the lounge, lively exchanges over lunch or dinner, and even an afternoon walk with fellows around campus. These informal encounters often stayed with me and shaped my thinking in surprising ways.

What advice would you give to a young scholar in your field?

It’s more of my experience rather than advice, that is, to stay positive and open-minded. Research rarely follows the path you first imagine, but in my experience, the most exciting ideas often emerge when you adapt and embrace unexpected opportunities.

What is on the horizon for you? What's next?

I will continue working on my book manuscript and plan to conduct new fieldwork in Asia and Europe to enrich the qualitative side of the project. At the same time, I am excited to launch my second book-length project, which explores how emerging technologies are pushing states and firms to forge new strategic relationships to facilitate innovation and govern technological change.

Local Governments Drive Most Industrial Policymaking

The data show that roughly 80 percent of industrial policies originate from local governments, including provinces, cities, and counties, while only about 13 percent come from the central government. This pattern highlights the importance of local initiative in shaping China’s industrial landscape.

Over time, however, the researchers find that central influence has grown, with greater policy coordination across different levels of government, especially since the early 2010s.

Policy Tools Evolve as Industries Mature

The study finds that China uses a wide range of tools to carry out its industrial policies, including fiscal subsidies, market access and regulation policies, support technology R&D and adoption, labor policy, and tax incentives, among others. 

The composition of these tools shifts systematically as industries develop.

• Emerging industries tend to receive entry-oriented support such as subsidies and land incentives.
• Mature-industry policies more often target R&D, labor and skills development, supply chain coordination, and consumer-side demand stimulation.

This evolution shows a clear pattern in how governments adjust policy instruments over time.

Imitation is Widespread — and Linked to Weaker Results

Many local governments replicate industrial policies from other regions, particularly from cities within the same province. This imitation contributes to policy duplication, inefficient competition, and industrial overcapacity when multiple localities pursue the same sectors or strategies.

Empirically, the study shows that “follower cities” — those that copy policy language or design from others and upper level governments without nuanced local adaptations — experience smaller gains in firm sales, profits, and productivity compared with cities that create original policies. The findings highlight how widespread imitation can dilute the effectiveness of local policy initiatives.

Different Tools Yield Different Firm Outcomes

By linking policy activity to firm-level data, researchers identify how industrial support affects businesses:

• Industries targeted with supportive policies are more likely to receive subsidies, higher tax deduction rates, and long-term loans.
• Fiscal and land subsidies are associated with higher rates of firm entry and investment.
• R&D support, cluster development, and equity investment show stronger correlations with productivity growth.

These findings highlight the diversity of policy instruments and their varied associations with firm performance.

A Comprehensive View of China’s Policy Landscape

Together, the results provide an unprecedented data-driven map of China’s industrial policymaking from 2000 to 2022.

The dataset—covering millions of documents and thousands of firms—offers a new empirical foundation for understanding how industrial policies are designed, implemented, and adapted over time.
 

Professor Hanming Fang is an applied microeconomist with broad theoretical and empirical interests focusing on public economics. His research integrates rigorous modeling with careful data analysis and has focused on the economic analysis of discrimination; insurance markets, particularly life insurance and health insurance; and health care, including Medicare. 

Hanming Fang is Norman C. Grosman Professor of Economics at the University of Pennsylvania. In early 2026, Professor Fang will join the Stanford Center on China’s Economy and Institutions as a Skyline Scholar. During his appointment he will participate in a rich spectrum of activities including expert talks and collaborative research efforts.
 

The world’s health systems face a complex and interconnected set of challenges that threaten to outpace our capacity to respond. Geopolitical fragmentation, climatic breakdown, technological disruption, pandemic threats, and misinformation have converged to strain the foundations of global health.  Building resilient global health systems requires five urgent reforms: sharpening the mandate of the World Health Organization (WHO), operationalizing the One Health concept, modernizing procurement, addressing the climate–health nexus, and mobilizing innovative financing. Together, these shifts can move the world from fragmented, reactive crisis management to proactive, equitable, and sustainable health security.

Emerging and Escalating Threats

While the global community demonstrated remarkable resilience in weathering the COVID-19 pandemic, the crisis also exposed profound structural weaknesses in global health governance and architecture. Chronic underinvestment in health systems led to coverage gaps, workforce shortages, and inadequate surveillance systems. The pandemic also revealed a fragmented global health architecture, plagued by institutional silos among key agencies (Elnaiem et al. 2023).

Years later, the aftershocks of the pandemic still resonate worldwide, with the ongoing triple burden of disease—the unfinished agenda of maternal and child health, the rising silent pandemic of noncommunicable diseases, and the reemergence of communicable diseases. These challenges, combined with the persistent challenge of malnutrition, unmet needs in early childhood development, growing concerns around mental health, and the threat of other emerging diseases, as well as the rising toll of trauma, injury, and aging populations, have placed countries across the world under immense strain. Health systems face acute infrastructure gaps, critical workforce shortages, and persistent inequities in service delivery, making it increasingly difficult to address the complex and evolving health needs of their populations. Post-pandemic fiscal tightening has constrained health budgets with debt-to-GDP ratios exceeding 70–80% in parts of the region (UN ESCAP 2023).

 Furthermore, climate change is fundamentally redefining the risk landscape. Rising temperatures, more frequent floods, intensifying storms, and shifting vector ranges for organisms like mosquitoes and ticks are disrupting food systems, displacing populations, and driving new patterns of disease transmission. Over the next 25 years in low- and middle-income countries, climate change could cause over 15 million excess deaths, and economic losses related to health risks from climate change could surpass $20.8 trillion (World Bank 2024). The cost of inaction has never been higher.

Meanwhile, deepening political polarization is amplifying conflict and weakening the global cooperation essential for scientific progress. The number of geopolitical disturbances worldwide is at an all-time high, displacing over 122 million people and eroding access to essential health services (UNHCR 2024). In 2023, false and conspiratorial health claims amassed over 4 billion views across digital platforms, compromising vaccine uptake and fueling health-related conspiracy theories. (Kisa and Kisa 2025). Furthermore, exponential technological advances in artificial intelligence are outpacing public health governance systems, creating new ethical and equity dilemmas. Global development assistance for health has significantly declined by more than $10 billion, with sharp cuts driven by the United States. This decline is likely to continue over the next five years (Institute for Health Metrics and Evaluation 2025).

Image

Note: Development assistance for health is measured in 2023 real US dollars; 2025 data are preliminary estimates.

Source: Institute for Health Metrics and Evaluation 2025.
 

Sign up for APARC newsletters to receive our experts' updates >

Five Critical Reform Directions for Future-Proofing Global Health Systems

1.    WHO matters more than ever — but only if it sharpens its focus.

The World Health Organization remains the technical backbone of global health, with a mandate to set norms and standards, shape research agendas, monitor health trends, coordinate emergency responses and regulation, and provide technical assistance. COVID-19 underscored both its indispensability and its limitations. During the pandemic, WHO convened states, disseminated guidance, and spearheaded initiatives like the Solidarity Trial and COVAX to promote vaccine equity, illustrating why it remains vital as the only neutral platform where 194 member states can cooperate on pandemics, antimicrobial resistance, or climate-related health risks. Its work on universal health coverage, the “triple burden” of disease, and global health data continues to anchor policy across countries.

At the same time, the crisis exposed structural weaknesses: WHO lacks enforcement authority, relies heavily on voluntary donor-driven funding, and sometimes stretches beyond its comparative strengths. When it shifts from convening and technical guidance into direct fund management, logistics, or large-scale program delivery, it risks diluting its mandate and eroding trust. Critics argue this reflects a broader challenge of an expansive mandate and donor-driven mission creep, pushing WHO beyond what 7,000 staff and a modest budget can realistically deliver. The way forward lies in sharpening focus: leveraging its convening power and legitimacy, providing technical expertise and evidence-based guidance, coordinating emergencies under the International Health Regulations, and advocating for equity in access to medicines and care. Anchored in these core strengths, a more agile WHO can better lead during crises, sustain credibility, and ensure that global health standards are consistently applied across diverse national contexts.

2.    Animal Health as the Next Frontier

More than 70 percent of emerging infectious diseases are zoonotic in origin, with roughly three-quarters of newly detected pathogens in recent decades spilling over from animals into humans (WHO 2022; Jones, Patel, Levy, et al. 2008). The economic costs are staggering: the World Bank estimates that zoonotic outbreaks have cost the global economy over $120 billion between 1997 and 2009 through crises such as Nipah, SARS, H5N1, and H1N1 (World Bank 2012). The drivers of spillover are intensifying due to deforestation and land-use change, industrial livestock farming, wildlife trade, and climate change. These are further accelerating the emergence of novel pathogens. 

However, the governance of animal health remains fragmented. While WHO, the Food and Agriculture Organization (FAO), and the World Organization for Animal Health (WOAH) each hold mandates, they often operate in silos. The Quadripartite, expanded in 2021 to include the United Nations Environment Programme, launched a One Health Joint Plan of Action (2022–26), but it remains underfunded and lacks strong political commitment. 

There is an urgent need to move One Health from principle to practice. To fill this governance gap, the world should consider establishing an independent intergovernmental alliance for animal health with a clear mandate. This could strengthen global One Health response by augmenting joint surveillance, building veterinary workforce capacity, and integrating environmental data into early warning systems. Such an alliance should avoid creating new bureaucratic layers and instead leverage the Quadripartite as its operational backbone. Embedding One Health into national health strategies and cross-sectoral policies would enable animal, human, and environmental health systems to work in tandem and address risks at their source. Preventive investments are also very cost-effective; the World Bank estimates that annual One Health prevention investments of $10–11 billion could save multiple times that amount in avoided pandemic losses (World Bank 2012). Strengthening One Health is both a health and economic necessity. 

3.    Agile Procurement: The Missing Link in Global Health Security

COVID-19 revealed how vital procurement and financial management are to global health security. A system built for routine procurement was suddenly called upon to handle crisis response on a worldwide scale, and it struggled to keep up. When vaccines became available, strict procedures, fragmented supply chains, and export restrictions meant access was uneven and often delayed. Developed countries’ advance purchase agreements stockpiled most of the supply, leaving many low- and middle-income countries waiting for doses. Within the UN system and its partners, overly complex procurement rules slowed the speed to market, and the lack of harmonized regulatory recognition caused further delays. As a result, those least able to handle shocks faced the longest waits and highest costs.

Reform must begin by making procurement agile, transparent, and equitable. Emergency playbooks should be pre-cleared to ensure that indemnity clauses and quality assurance requirements can be activated immediately when the next crisis arises. Regional pooled procurement mechanisms, like the Pan American Health Organization’s Revolving Fund or the African Union’s pooled initiatives, should be expanded to diversify supply sources and anchor distributed manufacturing. End-to-end e-procurement platforms would provide real-time shipment tracking, facility-level stock visibility, and open dashboards to strengthen accountability. Financial management must be integrated with procurement so that contingency funds, countercyclical reserves, and fast-disbursing credit lines can release resources in tandem with purchase orders. Together, these reforms would ensure that in future health emergencies, these procurement systems act as lifelines rather than bottlenecks.

4.    Addressing the Health–Climate Nexus

Climate change poses severe health risks, disproportionately affecting women and vulnerable populations in developing countries through heatwaves, poor air quality, food and water insecurity, and the spread of infectious diseases. Climate-related disasters are increasing in frequency and severity worldwide, reshaping both economies and health systems. In 2022, there were 308 climate-related disasters worldwide, ranging from floods and storms to droughts and wildfires (ADRC 2022). These events generated an estimated $270 billion in overall economic losses, with only about $120 billion insured—underscoring the disproportionate burden on low- and middle-income countries where resilience and coverage remain limited (Munich Re 2023). Over the past two decades, Asia and the Pacific have consistently been the most disaster-prone regions, accounting for nearly 40% of all global events, but every continent is now affected, from prolonged droughts in Africa and mega storms in North America to record-breaking heatwaves in Europe (UNEP n.d.).

Meeting this challenge requires a dual agenda of adaptation and mitigation. Health systems must be made climate-resilient by hardening infrastructure against floods and storms, ensuring reliable, clean energy in clinics and hospitals, and building climate-informed surveillance and early-warning systems that can anticipate disease outbreaks linked to environmental change. Supply chains need redundancy and flexibility to withstand shocks, and frontline workers require training to manage climate-driven health crises. At the same time, health systems must rapidly decarbonize. This means greening procurement and supply chains, phasing out high-emission medical products like certain inhalers and anesthetic gases, upgrading buildings and transport fleets, and embedding sustainability into financing and governance. Momentum is growing. The 2023 G20 Summit in Delhi, supported by the Asian Development Bank (ADB), recognized the health–climate nexus as a global priority, and institutions such as WHO, the World Bank, and ADB have begun to advance this agenda. The next step is to translate commitments into operational change by embedding climate-health strategies into national health plans, financing frameworks, and cross-sectoral policies. Climate action, sustainability, and resilience need to be integrated into the foundation of health systems.

5.    Mobilizing Innovative Financing

Strengthening health systems and preventing future pandemics will require massive financing, but global health funding is in decline. Innovative mechanisms to mobilize new resources are essential. This requires stronger engagement with finance ministries, development financing institutions, and the private sector to design models that attract and de-risk investment while enabling rapid disbursement during emergencies. International financing institutions (IFIs) need to unlock innovative financial pathways to amplify health investments. They need to deploy blended finance initiatives, public-private partnerships, guarantees, debt swaps, and outcome-based financing tools to mobilize private capital for health. Over the past few years, IFIs have committed billions in health-related financing worldwide. This has included landmark support for vaccine access facilities, delivery of hundreds of millions of COVID-19 vaccine doses, and mobilization of large-scale response packages that combine grants, loans, and technical assistance. 

There is a need to broaden the financing mandate beyond investing in universal health coverage and mobilize capital for emerging areas, including the climate-health nexus, mental health, nutrition, rapid urbanization, demographic shifts, digitization, and non-communicable diseases. By leveraging their balance sheets, IFIs can generate a multiplier effect in fund mobilization and attract new financing actors. Innovative instruments are already demonstrating potential. For example, the International Finance Facility for Immunisation (IFFIm), which issues “vaccine bonds” backed by donor pledges, has raised over $8 billion for Gavi immunization programs (IFFIm 2022; Moody’s 2024).  Debt-for-health and debt-for-nature swaps have redirected debt service into social outcomes. For example, El Salvador’s 2019 Debt2Health agreement with Germany channeled approximately $11 million into strengthening its health system, while Seychelles’ debt-for-nature swap created SeyCCAT to finance marine conservation, yielding social and resilience co-benefits for coastal communities (Hu, Wang, Zhou, et al. 2024). Similarly, contingent financing facilities—such as the Innovative Finance Facility for Climate in Asia and the Pacific (IF-CAP) and the International Financing Facility for Education (IFFEd)—also hold significant potential for health (IFFEd n.d.; ADB n.d.).  These examples demonstrate how contingent financing and swaps can expand fiscal space without exacerbating debt distress.

This can create a virtuous cycle of facilitating investments that create regional cooperation for sustainable and scalable impact. In this vein, the G20 Pandemic Fund is a beacon of catalytic multilateralism funding in a fragmented world. Launched in 2022 with over $2 billion pooled from governments, philanthropies, and multilaterals, it strengthens pandemic preparedness in low- and middle-income countries. Every $1 awarded from the Pandemic Fund has mobilized an estimated $7 in additional financing. The fund demonstrates that nations can still unite around shared threats, offering hope and a template for collective action on global challenges.

Equally important is the ability to deploy funds rapidly in emergencies. During the COVID-19 pandemic, reserve and countercyclical funds, used by countries such as Germany, the Netherlands, and Lithuania, along with the Multilateral Development Bank’s fast-track financing facilities with streamlined approval and disbursement processes, provided urgent and timely financing support (Sagan, Webb, Azzopardi-Muscat, et al. 2021; Lee and Aboneaaj 2021). These mechanisms should be institutionalized in national financial management systems as well as IFIs to ensure rapid funding disbursement in future health emergencies

Moving Forward

Delivering on this reform agenda requires more than technical fixes—it demands political will, sustained financing, and cross-sectoral collaboration. Member states must empower WHO to lead within its comparative strengths, while reinforcing One Health through stronger mandates and funding. Governments, IFIs, and the private sector should jointly design agile procurement and financing mechanisms that can be activated at speed during crises. Embedding health into climate policies and climate resilience into health strategies will ensure that future systems are both sustainable and resilient to shocks. Above all, reform efforts must be anchored in equity, so that the most vulnerable are protected first.

The opportunity before the global community is to reimagine health as the backbone of resilience and prosperity in the 21st century. A whole-of-systems approach is necessary to clarify mandates, integrate animal and environmental health, develop agile and fair procurement systems, embed climate action into health systems, and mobilize innovative financing. The steps taken in the next few years can lead to a more connected, cooperative, and future-ready global health architecture. 

Works Cited

ADB (Asia Development Bank). n.d. “IF-CAP: innovative Finance Facility for Climate in Asia and the Pacific.”

ADRC (Asian Disaster Reduction Center). Natural Disasters Data Book 2022. 

Elnaiem, Azza, Olaa Mohamed-Ahmed, Alimuddin Zumla, et al. 2023. “Global and Regional Governance of One Health and Implications for Global Health Security.” The Lancet 401 (10377): 688–704. 

Hu, Yunxuan, Zhebin Wang, Shuduo Zhou, et al. 2024. “Redefining Debt-to-Health, a Triple-Win Health Financing Instrument in Global Health.” Globalization and Health 20 (1): 39. 

Institute for Health Metrics and Evaluation. 2025. “Financing Global Health.” 

IFFEd (International Financing Facility for Education). n.d. “A Generation of Possibilities.” 

IFFIm (International Finance Facility for Immunisation). 2022. “How the World Bank Built Trust in Vaccine Bonds.” October 21. 

Jones, Kate E., Nikkita G. Patel, Marc A. Levy, et al. 2008. “Global Trends in Emerging Infectious Diseases.” Nature 451: 990–93. 

Kisa, Adnan, and Sezer Kisa. 2025. “Health Conspiracy Theories: A Scoping Review of Drivers, Impacts, and Countermeasures.” International Journal for Equity in Health 24 (1): 93.  

Lee, Nancy, and Rakan Aboneaaj. 2021. “MDB COVID-19 Crisis Response: Where Did the Money Go?” CGD Note, Center for Global Development, November. 

Moody’s. 2024. "International Finance Facility for Immunisation—Aa1 Stable” Credit opinion. October 29. 

Munich Re. 2023. “Climate Change and La Niña Driving Losses: The Natural Disaster Figures for 2022.” January 10. 

Sagan, Anna, Erin Webb, Natasha Azzopardi-Muscat, et al. 2021. Health Systems Resilience During COVID-19: Lessons for Building Back Better. World Health Organization and the European Observatory on Health Systems and Policies. 

UN ESCAP (United Nations Economic and Social Commission for Asia and the Pacific). 2023. “Public Debt Dashboard.” 

UNEP (United Nations Environment Programme). n.d. “Building Resilience to Disasters and Conflicts.” Accessed September 1, 2025. 

UNHCR (United Nations High Commissioner for Refugees). 2024. Global Trends Report. Copenhagen, Denmark. 

WHO (World Health Organization). 2022. Zoonoses and the Environment. 

World Bank. 2012. People, Pathogens and Our Planet: The Economics of One Health.  

World Bank. 2024. The Cost of Inaction: Quantifying the Impact of Climate Change on Health in Low- and Middle-Income Countries. Washington D.C. 

CDDRL Mosbacher Director Kathryn Stoner noted that: “This award is a powerful testament to the incredible quality of Erin and Brett’s pathbreaking research. Their work significantly advances our understanding of how modern authoritarian regimes function in the 21st century, and I am so pleased that our CDDRL community helped to support some of their scholarship. But this honor is all theirs!”

The William H. Riker Book Award adds to the growing recognition of the Carters’ research: Propaganda in Autocracies has also received the Hazel Gaudet-Erskine Best Book Award from the International Journal of Press/Politics, along with honorable mentions for both the APSA Luebbert Award for Best Book in Comparative Politics and the APSA Democracy and Autocracy Best Book Award.

With this honor, Erin Baggott Carter and Brett Carter join the distinguished ranks of scholars whose work carries forward William Riker’s legacy of combining theory and empirics to deepen our understanding of political life.

This opinion piece was first published by Project Syndicate >

STANFORD/LOS ANGELES – It is tempting to frame the Sino-American economic rivalry as a clash between engineering doers and lawyerly naysayers, as the Chinese-Canadian analyst Dan Wang does in his new book Breakneck: China’s Quest to Engineer the Future. But this is a false dichotomy, because law is a crucial feature of US capitalism.

We have heard the lawyers-versus-engineers argument before. Forty years ago, Japan’s economic rise induced similar anxieties, most famously articulated in the American sociologist Ezra Vogel’s book Japan as Number One: Lessons for America. Commentators fretted that America was mired in lawsuits while Japan’s best minds were solving problems and driving their country’s meteoric growth. Yet over the ensuing decades, the United States, with its mammoth legal industry, outperformed Japan by a wide margin.

Today’s panic about an Asian economic challenger is equally unwarranted and counterproductive. Invoking national security and the competition with China, Donald Trump’s administration is pursuing increasingly anti-capitalist and legally dubious interventions into private industry, with potentially high costs for American dynamism.

Continue reading at Project Syndicate >